New laser treatment could offer quicker relief for enlarged prostate

NCT ID NCT07289243

First seen Jan 04, 2026 · Last updated Jun 23, 2026 · Updated 23 times

Summary

This study compares a newer laser procedure (TPLA) to standard surgery (TURP) for men with urinary symptoms from an enlarged prostate. About 80 men will be randomly assigned to one of the two treatments. The main goal is to see if the laser works as well as surgery at easing symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RANDOMIZED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UOC Urologia e Trapianti di Rene Policlinico di Bari

    RECRUITING

    Bari, ITALY/Bari, 70124, Italy

  • UOC Urologia e Trapianti di Rene Policlinico di Bari

    ACTIVE_NOT_RECRUITING

    Bari, ITALY/Bari, 70124, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

laser ablation (TPLA) vs standard surgery (TURP)

What this could lead to

If TPLA works as well as TURP, it could offer a less invasive option for men with urinary symptoms from an enlarged prostate, possibly with a shorter hospital stay.

What could go wrong

This is a small, early-stage trial with only 80 participants, so results may not apply to everyone. The laser procedure might not be as effective as standard surgery, and there could be unknown risks.

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.